03/25/2024 5:02 PM | Delaet Ingrid (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/21/2024 3:20 PM | Delaet Ingrid (Reporting) Neurocrine Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/15/2024 4:25 PM | MORROW GEORGE J (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/15/2024 4:33 PM | BENEVICH ERIC (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/15/2024 4:15 PM | Delaet Ingrid (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/15/2024 4:19 PM | Neurocrine Biosciences (Issuer) POPS RICHARD F (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/14/2024 3:32 PM | BENEVICH ERIC (Reporting) Neurocrine Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
|
03/14/2024 3:33 PM | MORROW GEORGE J (Reporting) Neurocrine Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/12/2024 5:47 PM | Neurocrine Biosciences (Issuer) Neurocrine Biosciences (Issuer) POPS RICHARD F (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/12/2024 5:38 PM | Delaet Ingrid (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/08/2024 3:22 PM | Delaet Ingrid (Reporting) Neurocrine Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/08/2024 3:22 PM | Neurocrine Biosciences (Subject) POPS RICHARD F (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/29/2024 5:55 PM | BENEVICH ERIC (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/29/2024 6:02 PM | Delaet Ingrid (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/29/2024 5:50 PM | Neurocrine Biosciences (Issuer) Norwalk Leslie V (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/22/2024 4:11 PM | Neurocrine Biosciences (Issuer) POPS RICHARD F (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 4:51 PM | Neurocrine Biosciences (Issuer) ROBERTS EIRY (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 4:40 PM | Gano Kyle (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 4:43 PM | GORMAN KEVIN CHARLES (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 4:45 PM | Lippoldt Darin (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 4:48 PM | Neurocrine Biosciences (Issuer) Onyia Jude (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 4:27 PM | ABERNETHY MATT (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 4:29 PM | BENEVICH ERIC (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 4:33 PM | Boyer David W. (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 4:35 PM | Cooke Julie (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 4:38 PM | Delaet Ingrid (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 4:17 PM | GORMAN KEVIN CHARLES (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/13/2024 3:18 PM | ABERNETHY MATT (Reporting) Neurocrine Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/13/2024 3:19 PM | Lippoldt Darin (Reporting) Neurocrine Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/13/2024 3:19 PM | Neurocrine Biosciences (Subject) ROBERTS EIRY (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/13/2024 3:20 PM | Boyer David W. (Reporting) Neurocrine Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/13/2024 3:20 PM | GORMAN KEVIN CHARLES (Reporting) Neurocrine Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/09/2024 4:29 PM | Neurocrine Biosciences (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/08/2024 6:46 PM | Boyer David W. (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/08/2024 6:35 PM | Cooke Julie (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/08/2024 6:21 PM | GORMAN KEVIN CHARLES (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/08/2024 6:25 PM | Lippoldt Darin (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/08/2024 6:28 PM | Neurocrine Biosciences (Issuer) ROBERTS EIRY (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/08/2024 6:12 PM | ABERNETHY MATT (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/08/2024 6:15 PM | BENEVICH ERIC (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/08/2024 6:17 PM | Gano Kyle (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
AI to Meet the Same Fate as EVs? (Ad) When these tech bubbles burst, they invariably leave investors disillusioned by their losses.
Now, many worry a similar fate is awaiting AI.
And one man, legendary financial analyst Porter Stansberry, who called Nvidia at $11… Simply click here to read Porter’s warning on The Big AI Die-Up now. |
02/08/2024 3:21 PM | Boyer David W. (Reporting) Neurocrine Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/08/2024 3:21 PM | Boyer David W. (Reporting) Neurocrine Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/07/2024 6:00 AM | Neurocrine Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/02/2024 6:21 PM | GORMAN KEVIN CHARLES (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/02/2024 6:24 PM | Lippoldt Darin (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/02/2024 6:26 PM | Neurocrine Biosciences (Issuer) Onyia Jude (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/02/2024 6:29 PM | Neurocrine Biosciences (Issuer) ROBERTS EIRY (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/02/2024 6:00 PM | ABERNETHY MATT (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/02/2024 6:05 PM | BENEVICH ERIC (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/02/2024 6:07 PM | Boyer David W. (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/02/2024 6:11 PM | Cooke Julie (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/02/2024 6:14 PM | Delaet Ingrid (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/02/2024 6:17 PM | Gano Kyle (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/01/2024 3:43 PM | Delaet Ingrid (Reporting) Neurocrine Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/31/2024 4:04 PM | Delaet Ingrid (Reporting) Neurocrine Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/24/2024 4:47 PM | Lippoldt Darin (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/23/2024 10:52 AM | BlackRock Inc. (Filed by) Neurocrine Biosciences (Subject)
| Form SC 13G/A | |
01/22/2024 3:17 PM | Lippoldt Darin (Reporting) Neurocrine Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/10/2024 3:31 PM | GORMAN KEVIN CHARLES (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/08/2024 3:15 PM | GORMAN KEVIN CHARLES (Reporting) Neurocrine Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/04/2024 5:26 PM | Neurocrine Biosciences (Issuer) RASTETTER WILLIAM H (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/04/2024 5:32 PM | Gano Kyle (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/02/2024 3:31 PM | Neurocrine Biosciences (Subject) RASTETTER WILLIAM H (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/02/2024 3:31 PM | Gano Kyle (Reporting) Neurocrine Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/27/2023 3:08 PM | Cooke Julie (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/27/2023 3:10 PM | LYONS GARY A (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/27/2023 3:15 PM | Neurocrine Biosciences (Issuer) ROBERTS EIRY (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/22/2023 3:21 PM | Cooke Julie (Reporting) Neurocrine Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/22/2023 3:22 PM | Neurocrine Biosciences (Subject) ROBERTS EIRY (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/22/2023 3:22 PM | LYONS GARY A (Reporting) Neurocrine Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/14/2023 4:22 PM | Neurocrine Biosciences (Issuer) ROBERTS EIRY (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/11/2023 5:18 PM | Neurocrine Biosciences (Issuer) ROBERTS EIRY (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/08/2023 6:09 PM | Neurocrine Biosciences (Issuer) ROBERTS EIRY (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/08/2023 5:23 PM | Lippoldt Darin (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/06/2023 3:32 PM | Neurocrine Biosciences (Subject) ROBERTS EIRY (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/06/2023 3:33 PM | Lippoldt Darin (Reporting) Neurocrine Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/05/2023 3:54 PM | LYONS GARY A (Reporting) Neurocrine Biosciences (Issuer) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/01/2023 7:01 PM | LYONS GARY A (Reporting) Neurocrine Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/01/2023 4:41 PM | Neurocrine Biosciences (Issuer) Onyia Jude (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/29/2023 3:36 PM | Lippoldt Darin (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/29/2023 3:12 PM | Neurocrine Biosciences (Subject) Onyia Jude (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/13/2023 6:01 AM | Neurocrine Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/31/2023 6:01 AM | Neurocrine Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/31/2023 6:02 AM | Neurocrine Biosciences (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
10/06/2023 8:00 AM | Neurocrine Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/05/2023 6:02 AM | Neurocrine Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/04/2023 4:07 PM | Boyer David W. (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/14/2023 3:51 PM | LYONS GARY A (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/12/2023 3:09 PM | LYONS GARY A (Reporting) Neurocrine Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/12/2023 6:31 AM | Neurocrine Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
AI to Meet the Same Fate as EVs? (Ad) When these tech bubbles burst, they invariably leave investors disillusioned by their losses.
Now, many worry a similar fate is awaiting AI.
And one man, legendary financial analyst Porter Stansberry, who called Nvidia at $11… Simply click here to read Porter’s warning on The Big AI Die-Up now. |
09/01/2023 3:36 PM | Boyer David W. (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/01/2023 3:31 PM | Lippoldt Darin (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/01/2023 3:16 PM | Cooke Julie (Reporting) Neurocrine Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/01/2023 3:18 PM | LYONS GARY A (Reporting) Neurocrine Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/30/2023 3:42 PM | Boyer David W. (Reporting) Neurocrine Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/30/2023 3:38 PM | Delaet Ingrid (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/23/2023 7:20 PM | Neurocrine Biosciences (Issuer) ROBERTS EIRY (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/23/2023 6:58 PM | ABERNETHY MATT (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/23/2023 6:59 PM | BENEVICH ERIC (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |